Match!
Paul-Louis Woerther
Paris 12 Val de Marne University
Intensive care medicineTigecyclineEnterococcus faecalisAntimicrobialBiology
3Publications
2H-index
8Citations
What is this?
Publications 8
Newest
#1Naouale Maataoui (French Institute of Health and Medical Research)
#2Céline LangendorfH-Index: 9
Last. Paul-Louis Woerther (Paris 12 Val de Marne University)H-Index: 2
view all 11 authors...
Source
#1Solen Kernéis (Pasteur Institute)H-Index: 11
#2Sandrine ValadeH-Index: 5
Last. Paul-Louis Woerther (Paris 12 Val de Marne University)H-Index: 2
view all 3 authors...
Source
#1Mehdi Ellouze (French Institute of Health and Medical Research)H-Index: 2
#2Lola Vigouroux (French Institute of Health and Medical Research)
Last. V. Godot (French Institute of Health and Medical Research)H-Index: 7
view all 17 authors...
Source
Source
#1Roman Mounier (Paris 12 Val de Marne University)H-Index: 4
#2Elodie Lang (Paris 12 Val de Marne University)H-Index: 1
Last. Lebeaux D (University of Paris)
view all 17 authors...
2 CitationsSource
#1G. Royer (Université Paris-Saclay)
#2E. Melloul (Paris 12 Val de Marne University)H-Index: 2
Last. Paul-Louis Woerther (Paris 12 Val de Marne University)H-Index: 2
view all 13 authors...
Source
#1Paul-Louis Woerther (Paris 12 Val de Marne University)H-Index: 2
#2R. LepeuleH-Index: 6
Last. François BarbierH-Index: 19
view all 6 authors...
ABSTRACT The ongoing pandemic of extended-spectrum β-lactamase-producing Enterobacteriaceae (ESBL-E) is responsible for a global rise in carbapenem consumption that may hasten the dissemination of carbapenemase-producing Enterobacteriaceae (CPE). Hence, carbapenem sparing through the use of alternative β-lactams is increasingly considered as a potential option in patients with ESBL-E infections. However, at the individual level, this strategy implies an in-depth understanding of how carbapenems ...
6 CitationsSource
Background A high level of antibiotic consumption in France means antimicrobial resistance requires rigorous monitoring. The Tigecycline Evaluation and Surveillance Trial (T.E.S.T.) is a global surveillance study that monitors the in vitro activities of tigecycline and a panel of marketed antimicrobials against clinically important Gram-positive and Gram-negative isolates.
2 CitationsSource
1